Baird Downgrades Evoqua Water Techs to Neutral, Maintains $49 Price Target
Baird analyst Michael Halloran downgrades Evoqua Water Techs (NYSE:AQUA) from Outperform to Neutral and maintains $49 price target.
Stifel Downgrades Atlas Technical to Hold, Raises Price Target to $12.25
Stifel analyst Noelle Dilts downgrades Atlas Technical (NASDAQ:ATCX) from Buy to Hold and raises the price target from $7.5 to $12.25.
Wells Fargo Downgrades Edison to Equal-Weight, Lowers Price Target to $73
Wells Fargo analyst Neil Kalton downgrades Edison (NYSE:EIX) from Overweight to Equal-Weight and lowers the price target from $76 to $73.
Piper Sandler Downgrades WSFS Financial to Neutral, Lowers Price Target to $52
Piper Sandler analyst Frank Schiraldi downgrades WSFS Financial (NASDAQ:WSFS) from Overweight to Neutral and lowers the price target from $53 to $52.
Goldman Sachs Downgrades Hasbro to Neutral, Announces $64 Price Target
Goldman Sachs analyst Stephen Laszczyk downgrades Hasbro (NASDAQ:HAS) from Buy to Neutral and announces $64 price target.
Wolfe Research Downgrades Jones Lang LaSalle to Peer Perform
Wolfe Research analyst Andrew Rosivach downgrades Jones Lang LaSalle (NYSE:JLL) from Outperform to Peer Perform.
Goldman Sachs Downgrades Equitrans Midstream to Sell, Lowers Price Target to $6
Goldman Sachs analyst John Mackay downgrades Equitrans Midstream (NYSE:ETRN) from Buy to Sell and lowers the price target from $9.5 to $6.
Truist Financial Analyst Downgrades Stock Citing Growing Deposit Competition, Unlikeliness Of Debt Recovery
Stephens & Co analyst Terry McEvoy downgraded Truist Financial Corp (NYSE:TFC) from Overweight to Equal-Weight and a $53 price target. On average,…
InVitae’s ‘Long, Uncertain Path’ Toward Profitability: Analyst Downgrades Biotech
Shares of Invitae Corp (NYSE: NVTA) came under pressure on Monday, after gaining more than 24% in January.
Despite having a restricting plan in place, the biotech company has a “long path to profitability,” according to Goldman Sachs.
Keefe, Bruyette & Woods Downgrades HomeStreet to Market Perform, Announces $29 Price Target
Keefe, Bruyette & Woods analyst Jacquelynne Bohlen downgrades HomeStreet (NASDAQ:HMST) from Outperform to Market Perform and announces $29 price target.